Status:
COMPLETED
A Study of Abatacept in Patients With Active Ulcerative Colitis
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active ulcerative colitis in patients who have not had an adequate response to other therapies. T...
Detailed Description
The Induction Period First Cohort (IP1C) arms (30/10 mg/kg and 10 mg/kg) were placebo-controlled arms that were used for the primary endpoint and its analysis. The Induction Period Second Cohort arms ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men or women 18 years or older
- Ulcerative colitis for at lease 3 months
- Moderate to severe active ulcerative colitis
- Inadequate response or intolerance to standard ulcerative colitis treatment
Exclusion
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
591 Patients enrolled
Trial Details
Trial ID
NCT00410410
Start Date
December 1 2006
End Date
November 1 2009
Last Update
March 24 2015
Active Locations (143)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Alabama At Birmingham
Birmingham, Alabama, United States, 35294
2
Mayo Clinic Arizona
Scottsdale, Arizona, United States, 85259
3
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
4
The Permanente Medical Group, Inc
Sacramento, California, United States, 95825